How selecting best therapy for metastatic NTRK fusion-positive non-small cell lung cancer?

The tropomyosin receptor kinase (TRK) family of receptor tyrosine kinases has become a focus of clinical interest because the NTRK genes (NTRK1-3) encoding them have been identified as oncogenic fusion genes in a wide range of different tumor types, including lung cancer. These NTRK gene fusions usu...

Descripción completa

Detalles Bibliográficos
Autor principal: Ekman, Simon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2020
Materias:
Review Article on Looking for Chimeras in NSCLC: Widen Therapeutic Options Targeting Oncogenic Fusions
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7815373/
https://www.ncbi.nlm.nih.gov/pubmed/33489816
http://dx.doi.org/10.21037/tlcr-20-434

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7815373/
https://www.ncbi.nlm.nih.gov/pubmed/33489816
http://dx.doi.org/10.21037/tlcr-20-434

Ejemplares similares